Last week, US pharma giant Pfizer chairman and chief executive Albert Bourla presented at the JP Morgan Healthcare Conference ...

US clinical-stage vaccines developer Vaxcyte on Friday provided updates on the continued advancement of VAX-31, the company’s ...

Belgian biopharma UCB has announced a capital boost from the UK government’s Life Sciences Innovative Manufacturing Fund ...

Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today, the UK health technology assessor, National Institute ...

Canadian pharma company Bausch Health has announced the results of the global Phase III RED-C clinical program.

South Korea’s Samsung Bioepis today released its first quarter 2026 biosimilar market report, marking the twelfth edition of ...

Australian biotech Neurizon Therapeutics (ASX: NUZ) is setting out to redefine how neurodegenerative diseases are treated, ...

Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to manufacture and ...

The USA has completed its withdrawal from the World Health Organization (WHO), according to a joint announcement by the US ...

US biopharma Corcept Therapeutics (Nasdaq: CORT) says its Phase III ROSELLA trial met its overall survival primary endpoint ...

In a new report, DelveInsight argues the gastroesophageal reflux disease market remains constrained by limited approved ...

The Russian government has extended the permit for domestic pharmaceutical companies Promomed and PSK Pharma to produce ...